Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: a single‐centre experience
Abstract Aims Heart failure with reduced ejection fraction (HFrEF) is associated with excessive sympathetic and impaired parasympathetic activity. The Barostim Neo™ device is used for electronical baroreflex activation therapy (BAT) to counteract autonomic nervous system dysbalance. Randomized trial...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2023-12-01
|
| Collection: | ESC Heart Failure |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1002/ehf2.14508 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|